Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IKT stock hub

Inhibikase Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IKTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

351.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IKT

In the news

Latest news · IKT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-36

P25 -105.6P50 -46.5P75 -3.1

ROIC-21.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IKT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001750149
Company name	Inhibikase Therapeutics, Inc.
Country	United States
Country code	US
Cusip	45719W106
Employees	35
Employees Change	19%
Employees Change Percent	118.8
Enterprise value	$172.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-12-23
Isin	US45719W2052
Last refreshed	2026-05-10
Market cap	$351.1M
Market cap category	Small-Cap
Price	$2.06
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	IKT
Website	https://www.inhibikase.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.74%
FCF yield	-7.92%
P/B ratio	2.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit Growth Q	133.95%
Net Income	$-48.3M
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-20.53
Roa5y	-36.33
ROCE	-26.57
ROE	-36.05
Roe5y	-65.8
ROIC	-21.44

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	11.36%
Cagr3y	-19.05%
Cagr5y	-42.37%
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$181.2M
Cash	$178.8M
Current Assets	$180.1M
Current Liabilities	$8.3M
Equity	$172.9M
Liabilities	$8.3M
Long Term Assets	$1.1M
Long Term Liabilities	$0
Net Cash	$178.8M
Net Cash By Market Cap	$50.91
Net Cash Growth	83.47%
Net Debt Equity	$-1.03
Tangible Book Value	$172.9M
Tangible Book Value Per Share	$1.02
WACC	9.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	21.7
Net Working Capital	$-7M
Quick ratio	21.54
Working Capital	$171.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-314.6%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	11.35%
200-day SMA	1.7
3Y total return	-46.97%
50-day SMA	1.84
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.64%
All Time High	70.8
All Time High Change	-97.09%
All Time High Date	2020-12-23
All Time Low	0.79
All Time Low Change	160.76%
All Time Low Date	2023-10-10
ATR	0.11
Beta	0.96
Beta1y	1.26
Beta2y	1.6
Ch YTD	0.49
High	2.1
High52	2.27
High52 Date	2025-05-14
High52ch	-9.25%
Low	1.95
Low52	1.33
Low52 Date	2025-11-03
Low52ch	54.89%
Ma50ch	12.08%
Premarket Change Percent	-0.33
Premarket Price	$1.98
Price vs 200-day SMA	21.25%
RSI	64.84
RSI Monthly	42.7
RSI Weekly	58.72
Sharpe ratio	0.46x
Sortino ratio	0.84
Total Return	-314.6%
Tr YTD	0.49
Tr1m	17.05%
Tr1w	7.85%
Tr3m	21.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	1
Analyst Price Target Top	$6
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.12
Operating Income	$-45.9M
Price target	$5
Price Target Change	$143
Price Target Change Top	$191

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	86,908,876%
Float Percent	50.99%
Shares Insiders	1.55%
Shares Institutions	46.06%
Shares Out	170,452,294
Shares Qo Q	37.3%
Shares Yo Y	314.6%
Short Float	20.47%
Short Ratio	11.48
Short Shares	10.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-43.1M
Average Volume	960,243.55x
Bv Per Share	1.02
CAPEX	$-13,399
Ch1m	17.05
Ch1w	7.85
Ch1y	11.35
Ch3m	21.18
Ch3y	-46.96
Ch5y	-93.64
Ch6m	37.33
Change	3.52%
Change From Open	4.04
Close	1.99
Days Gap	-0.5
Depreciation Amortization	60,499
Dollar Volume	1,968,958.3
Earnings Date	2026-03-26
Earnings Time	amc
EBIT	$-45.9M
EBITDA	$-45.9M
EPS	$-0.49
F Score	1
FCF	$-27.8M
FCF EV Yield	-16.13x
FCF Per Share	$-0.16
Financing CF	108,462,963
Fiscal Year End	December
Founded	2,008
Investing CF	2,053,130
Ipr	-79.4
Iprfo	-96.78
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Date	2023-06-30
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	1.71
Ma150ch	20.54%
Ma20	1.86
Ma20ch	10.75%
Net CF	82,729,629
Next Earnings Date	2026-08-13
Open	1.98
Optionable	No
Position In Range	73.33
Post Close	2.06
Postmarket Change Percent	0.49
Postmarket Price	$2.07
Pre Close	1.99
Price Date	2026-05-08
Ptbv Ratio	2.03
Relative Volume	1x
Share Based Comp	15,309,924
Tr6m	37.33%
Us State	Delaware
Volume	955,805

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IKT pay a dividend?

Capital-return profile for this ticker.

Performance

IKT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IKT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.1%

Float: +51.0% of shares outstanding

Insider ownership

+1.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IKT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.8

Neutral momentum band

Price vs 200-day MA

+21.2%

50/200-day relationship not available

Beta (5Y)

0.96

Moves roughly with the market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IKT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IKT stock rating?

Inhibikase Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IKT analysis?

The full report lives at /stocks/IKT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IKT?

The latest report frames IKT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IKT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.